News Sections

Newser Specials

Stories related to: Trasylol

Stories

2 Stories

February 2008
- FDA Delay Cost 22,000 Lives: Doctor
  
  newser | CBS | Feb 15, 08 7:53 AM CST
  
  A prominent researcher who revealed widespread fatalities associated with the heart surgery drug Trasylol says 22,000 people died because of the FDA's delay in blowing the whistle on the drug after his study was published. Drugmaker Bayer also failed to disclose negative results of its own study. In a 60 Minutes interview to air Sunday, Dr. Dennis Mangano says the FDA waited more than a year to pull Trasylol—until after it was banned in Germany. More »
  
  Tags
  
  FDA • pharmaceutical companies • heart surgery • Trasylol • Bayer Pharmaceuticals • kidney failure
November 2007
- Sales of Heart-Surgery Drug Halted
  
  newser | Washington Post | Nov 5, 07 9:35 PM CST
  
  Bayer Pharmaceuticals will suspend the sale of Trasylol, a drug used to control bleeding during heart bypass surgery, after a clinical study found that the drug puts patients at increased risk of death, the Washington Post reports. The FDA said sales of the drug would be halted at least until the agency had reviewed the study. More »
  
  Tags
  
  FDA • Trasylol • Bayer Pharmaceuticals

2 Stories

What is Newser?

Newser gives you more news in less time. We search for the best and most important stories all over the web, read them for you, and deliver concise and sharp summaries—along with links to the full text. Newser provides a way to stay on top of an ever-expanding horizon of news and opinion—politics, sports, business, trends, technology, personalities, crimes, and controversies. Newser keeps you not just better informed, but, with our signature graphic interface and smart condensed format, more enjoyably informed.

Learn more »